SHANGHAI, Sept 4 (Reuters) - China's 3SBio Inc has agreed to buy the contract development and manufacturing unit of Canada's Therapure Biopharma Inc for $290 million, part of a push by the Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback